HopeStage
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
More filters: keywords, city, remote
1326studies shown
Showing 169-180 of 1,326
Other study type icon
RecruitingNCT06872398

Medical Comorbidities in Bipolarity

Official study title

Medical Comorbidities in Bipolar Disorder : Clinical Validation of Risk Factors and Biomarkers to Improve Prevention and Treatment;

In France
BipolarityObservational studyAges 18–65
Countries
France
Sponsor
Fondation FondaMental
Other study type icon
RecruitingNCT05878730

Melatonin and Response to Lithium

What is this study about?

Researchers compare overnight melatonin-related urine measurements in people with bipolarity type I who respond well or poorly to lithium, while their mood is stable. They want to understand whether body-clock biology helps explain differences in lithium response; melatonin is being measured, not given as treatment.

In France
BipolarityObservational studyAges 18–70
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Other study type icon
RecruitingNCT05973643

Metabolomics During ElectroConvulsivoTherapy

Official study title

Study by 1H NMR of the Variations of the Metabolome During the Course of Electroconvulsive Therapy in Patients With Major Depressive Episode

In France
DepressionInterventional studyAges 18+
Countries
France
Sponsor
Hôpital le Vinatier
Behavioral study icon
RecruitingNCT06906328

MEthylphenidate for ADHD

Official study title

MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response

In France
ADHD, AddictionBehavioural studyAges 18–99
Countries
France
Sponsor
Nantes University Hospital
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.